Stock listing
BOATS:PRLD Prelude Therapeutics Incorporated Stock
US listing (BOATS) of Prelude Therapeutics Incorporated · home listing NASDAQ:PRLD
Follow Prelude Therapeutics Incorporated into a list and get an email when it puts out news.
Home listing price · NASDAQ:PRLD
$3.53 USD +0.14 (+4.1%)
Close on Oct 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:PRLD
- Day range
- $3.35 – $3.61 USDOct 20, 2026
- Volume
- 357,000 sharesOct 20, 2026
- Market cap
- $281.7M USDAt the close on Oct 20, 2026 · price × 79.80M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:PRLD · Home | $3.53 USD | +0.14 (+4.1%) | 357,000 | $3.40 | $3.61 | $3.35 | $3.39 | Close on Oct 20, 2026 |
Daily closes
Last 3 months, Jul 20, 2026 – Oct 20, 2026 · NASDAQ:PRLD · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $3.53 | +0.14 | +4.1% | $3.40 | $3.61 | $3.35 | 357,000 | |
| $3.39 | +0.13 | +4.0% | $3.28 | $3.42 | $3.26 | 1,587,664 | |
| $3.26 | -0.06 | -1.8% | $3.322 | $3.41 | $3.19 | 479,270 | |
| $3.32 | +0.09 | +2.8% | $3.23 | $3.44 | $3.20 | 400,242 | |
| $3.23 | -0.33 | -9.3% | $3.50 | $3.50 | $3.205 | 488,359 | |
| $3.56 | -0.18 | -4.8% | $3.74 | $3.897 | $3.43 | 672,671 | |
| $3.74 | -0.15 | -3.9% | $3.91 | $3.94 | $3.74 | 196,549 | |
| $3.89 | +0.01 | +0.3% | $3.87 | $4.03 | $3.85 | 341,647 | |
| $3.88 | +0.05 | +1.3% | $3.77 | $3.95 | $3.66 | 424,097 | |
| $3.83 | +0.02 | +0.5% | $3.835 | $3.93 | $3.69 | 454,600 | |
| $3.81 | +0.04 | +1.1% | $3.78 | $3.82 | $3.68 | 382,400 | |
| $3.77 | +0.10 | +2.7% | $3.68 | $3.81 | $3.55 | 324,300 | |
| $3.67 | -0.12 | -3.2% | $3.75 | $3.815 | $3.63 | 742,000 | |
| $3.79 | -0.12 | -3.1% | $3.90 | $3.94 | $3.59 | 502,500 | |
| $3.91 | -0.05 | -1.3% | $4.02 | $4.02 | $3.86 | 702,600 | |
| $3.96 | +0.05 | +1.3% | $3.95 | $4.00 | $3.83 | 457,900 | |
| $3.91 | +0.035 | +0.9% | $3.845 | $3.98 | $3.72 | 496,200 | |
| $3.875 | -0.115 | -2.9% | $4.00 | $4.05 | $3.83 | 336,200 | |
| $3.99 | -0.32 | -7.4% | $4.31 | $4.32 | $3.863 | 1,039,900 | |
| $4.31 | -0.54 | -11.1% | $4.85 | $4.87 | $4.163 | 704,300 | |
| $4.85 | +0.15 | +3.2% | $4.70 | $4.91 | $4.63 | 424,400 | |
| $4.70 | -0.17 | -3.5% | $4.88 | $4.905 | $4.69 | 390,300 | |
| $4.87 | +0.30 | +6.6% | $4.58 | $4.87 | $4.51 | 1,164,400 | |
| $4.57 | +0.10 | +2.2% | $4.79 | $4.91 | $4.49 | 533,000 | |
| $4.47 | -0.05 | -1.1% | $4.55 | $4.65 | $4.36 | 191,400 | |
| $4.52 | -0.07 | -1.5% | $4.56 | $4.58 | $4.40 | 262,700 | |
| $4.59 | 0.00 | 0.0% | $4.60 | $4.68 | $4.50 | 274,600 | |
| $4.59 | -0.08 | -1.7% | $4.72 | $4.75 | $4.56 | 520,300 | |
| $4.67 | -0.42 | -8.3% | $5.04 | $5.22 | $4.64 | 561,900 | |
| $5.09 | -0.21 | -4.0% | $5.25 | $5.34 | $5.06 | 311,900 | |
| $5.30 | -0.16 | -2.9% | $5.38 | $5.46 | $5.19 | 257,900 | |
| $5.46 | +0.21 | +4.0% | $5.19 | $5.519 | $5.19 | 400,300 | |
| $5.25 | -0.18 | -3.3% | $5.44 | $5.62 | $5.11 | 578,000 | |
| $5.43 | -0.06 | -1.1% | $5.53 | $5.82 | $5.30 | 355,100 | |
| $5.49 | -0.11 | -2.0% | $5.55 | $5.61 | $5.25 | 538,400 | |
| $5.60 | +0.13 | +2.4% | $5.39 | $5.629 | $5.235 | 737,600 | |
| $5.47 | -0.87 | -13.7% | $6.27 | $6.379 | $5.42 | 725,100 | |
| $6.34 | -0.22 | -3.4% | $6.48 | $6.61 | $6.21 | 364,400 | |
| $6.56 | -0.03 | -0.5% | $6.61 | $6.71 | $6.37 | 463,200 | |
| $6.59 | +0.12 | +1.9% | $6.57 | $6.695 | $6.31 | 415,400 | |
| $6.47 | -0.16 | -2.4% | $6.64 | $6.83 | $6.115 | 515,700 | |
| $6.63 | +0.13 | +2.0% | $6.56 | $6.816 | $6.40 | 516,100 | |
| $6.50 | +0.72 | +12.5% | $5.70 | $6.65 | $5.70 | 2,438,800 | |
| $5.78 | +0.03 | +0.5% | $5.84 | $5.90 | $5.66 | 421,500 | |
| $5.75 | +0.12 | +2.1% | $5.62 | $5.78 | $5.485 | 268,400 | |
| $5.63 | +0.08 | +1.4% | $5.57 | $5.86 | $5.45 | 265,300 | |
| $5.55 | +0.19 | +3.5% | $5.45 | $5.61 | $5.15 | 452,100 | |
| $5.36 | -0.37 | -6.5% | $5.77 | $5.91 | $5.21 | 888,100 | |
| $5.73 | +0.41 | +7.7% | $5.39 | $5.897 | $5.39 | 623,900 | |
| $5.32 | +0.49 | +10.1% | $4.95 | $5.85 | $4.83 | 698,441 | |
| $4.83 | -0.07 | -1.4% | $4.91 | $5.00 | $4.81 | 217,169 | |
| $4.90 | +0.22 | +4.7% | $4.74 | $4.915 | $4.63 | 165,700 | |
| $4.68 | +0.14 | +3.1% | $4.47 | $4.75 | $4.47 | 242,300 | |
| $4.54 | +0.02 | +0.4% | $4.51 | $4.595 | $4.37 | 158,300 | |
| $4.52 | +0.13 | +3.0% | $4.41 | $4.58 | $4.405 | 218,800 | |
| $4.39 | -0.21 | -4.6% | $4.65 | $4.65 | $4.35 | 288,700 | |
| $4.60 | -0.45 | -8.9% | $5.03 | $5.15 | $4.57 | 292,400 | |
| $5.05 | +0.34 | +7.2% | $4.71 | $5.13 | $4.71 | 329,800 | |
| $4.71 | +0.07 | +1.5% | $4.64 | $4.98 | $4.315 | 485,300 | |
| $4.64 | +0.75 | +19.3% | $4.55 | $4.87 | $4.19 | 1,855,600 | |
| $3.89 | +0.06 | +1.6% | $3.86 | $4.045 | $3.86 | 179,400 | |
| $3.83 | -0.10 | -2.5% | $3.95 | $3.95 | $3.77 | 284,200 | |
| $3.93 | +0.005 | +0.1% | $3.84 | $3.964 | $3.77 | 205,900 | |
| $3.925 | -0.115 | -2.8% | $4.02 | $4.065 | $3.896 | 171,100 | |
| $4.04 | -0.02 | -0.5% | $4.03 | $4.205 | $4.01 | 145,600 | |
| $4.06 | -0.14 | -3.3% | $4.24 | $4.32 | $3.95 | 284,100 |
- Ticker
- BOATS:PRLD
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Oct 16, 2026
Prelude Therapeutics to Participate in the Chardan Healthcare Conference
Latest earnings call · Nov 12, 2025
Prelude Therapeutics (NASDAQ:PRLD) Q3 2025 Earnings Call
Replay and transcript
Latest deck · Sep 10, 2026
Investor Presentation (September 2026)
Investor deck · 34 slides
Calls
Replays
Prelude Therapeutics (NASDAQ:PRLD) Q3 2025 Earnings Call
Wed, Nov 12, 2025 · 8:00 AM ET
Watch Transcript
Latest news
Prelude Therapeutics to Participate in the Chardan Healthcare Conference
Oct 16, 2026
Closed $3.39 (+4.0%) on Oct 19, 2026
Prelude Announces Clinical Trial Collaboration and Supply Agreement with Lilly to Evaluate KAT6A Selective Degrader PRT13722 in Combination with Verzenio® and Inluriyo® in Patients with HR+/HER2- Breast Cancer
Oct 13, 2026
Closed $3.56 (-4.8%) on Oct 13, 2026
Prelude Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Sep 11, 2026
Closed $4.59 (-1.7%) on Sep 11, 2026
Prelude Therapeutics Receives FDA Clearance of Investigational New Drug (IND) Application for PRT13722, Its First-in-Class Oral KAT6A Selective Degrader
Sep 10, 2026
Closed $4.67 (-8.3%) on Sep 10, 2026
Prelude Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Aug 11, 2026
Closed $5.32 (+10.1%) on Aug 11, 2026
Decks
Investor Presentation (September 2026)
Investor deck · 34 slides · Sep 10, 2026
Investor Presentation (May 2026)
Investor deck · 27 slides · May 12, 2026
Investor Presentation (April 2026)
Investor deck · 27 slides · Apr 20, 2026
Investor Presentation (March 2026)
Investor deck · 26 slides · Mar 10, 2026
Prelude Therapeutics Incorporated on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 16 in the last 12 months · 83 in all · newest Oct 16, 2026 · oldest 2020
- Calls
- 1 call with a replay · 1 with a transcript · latest Nov 12, 2025
- Decks
- 34 decks · latest Sep 10, 2026
Where Prelude Therapeutics Incorporated is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:PRLD · Home listing | NASDAQ | United States | USD |
| BOATS:PRLD · This page | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Prelude Therapeutics Incorporated.